Paediatric vaccines in BRIC/emerging markets

Background and objectives

Lifescience Dynamics was invited to investigate opportunities for expansion of our client's paediatric vaccines in Brazil, Russia, India, China, Mexico and Turkey.

Objectives included market understanding, pricing points in the private market, concept testing and development of ideal product profiles.

Approach

Key opinion leaders, policy makers and influencers, front line doctors and parents were interviewed in the target market.

• Research was conducted in person and over the phone

Results delivered

• Burden of influenza disease and seriousness of influenza in young children
• How clinical trials should be set up
• Barriers to vaccination included
• Price points prophylaxis for national coverage via government initiatives
• Key decision makers for vaccinations: government guidelines, family practitioners, paediatricians, nursery entrance requirements, family elders and parents
  • Price points prophylaxis for where both parents work as well as where only one works